Cipla in vaccines deal for SA

Indian generic drug maker Cipla said yesterday that it had agreed to an exclusive deal with Serum Institute of India to supply vaccines to SA, adding a new market to their partnership in India and Europe. Cipla’s local subsidiary, Cipla Medpro, will be responsible for obtaining local regulatory approval and marketing the vaccines in SA.